Docetaxel Alternatives Compared
Docetaxel | Kisqali | Enhertu |
|
---|
Docetaxel | Kisqali (ribociclib) | Enhertu (fam-trastuzumab deruxtecan) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer, Prostate Cancer, Gastric Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Solid Tumors. docetaxel may also be used for purposes not... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. Kisqali may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Gastric Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Solid Tumors. Enhertu may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Docetaxel | More about Kisqali (ribociclib) | More about Enhertu (fam-trastuzumab deruxtecan) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Docetaxel has an average rating of 4.5 out of 10 from a total of 15 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 50% reported a negative effect. |
Kisqali has an average rating of 8.5 out of 10 from a total of 24 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 4% reported a negative effect. |
Enhertu has an average rating of 7.9 out of 10 from a total of 21 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: docetaxel side effects in more detail. |
See also: Kisqali side effects in more detail. |
See also: Enhertu side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all docetaxel prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Enhertu prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Docivyx, Taxotere |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
11.1 hours |
54.7 hours |
136.8 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 479 drugs are known to interact with docetaxel:
|
A total of 708 drugs are known to interact with Kisqali:
|
A total of 165 drugs are known to interact with Enhertu:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
November 22, 2022 |
March 13, 2017 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.